TLR4 and Sepsis: Evidence of TLR4 activation having a negative influence on outcomes following severe infection has been demonstrated in previous studies using mouse models [17–19], showing that blockade of TLR4 inhibited systemic inflammatory responses in sepsis, which reduced the disease severity and lethality.